Experimental Drug Holds Promise to Reduce Stroke Risk

A new drug developed as an alternative to popular drug warfarin, also used as rat poison, has been found to significantly reduce stroke risk.

Generally, patients at risk of stroke are given warfarin to prevent blood clotting, but the treatment is risky and requires regular monitoring.

Stroke – Early Warning Signs - Risk Factor - Rehab - Treatment
Stroke can cause permanent disability and it is important to recognize its early warning signs to stop its progress. Early warning signs of stroke include sudden weakness of facial muscles.

In the new study, the doctors found that the new drug, dabigatran (Pradaxa), was 34 per cent more effective at reducing the risk of stroke and blood clots in at-risk patients than well-controlled warfarin.

It also reduced death rates by 15 per cent.

In the three-year long study, the researchers recruited patients with an average age of 71, all of whom suffered from atrial fibrillation, a heart rhythm disorder that greatly increases the risk of stroke.

Top 10 Facts on Stroke
Strokes occur when the blood flow to an area of the brain is cut off. It is imperative to detect the signs of a stroke and rush the patient to the hospital at once. Here are some interesting facts on stroke.

The British Heart Foundation said that the results for an alternative to warfarin were promising, but the drug would not be available to patients until next year at the earliest.

"Warfarin is a highly effective treatment when indicated for stroke prevention, but it is underused, often because of safety concerns or the need for regular blood tests to monitor its effects," Times Online quoted Keith Muir, a medical advisor for the Stroke Association, as saying.

Stroke-I - Introduction
Distance education for Stroke-I

The trial indicates that dabigatran may offer a useful alternative to warfarin for stroke prevention in some circumstances.

"However, the trial only involved people who could equally well have taken warfarin, and anyone currently taking warfarin should continue it unless advised by their doctor," he added.

Blood Clot Drug Touted to Save Lives After Surgery
Charity Lifeblood has called on doctors to use blood-thinning drug Pradaxa (dabigatran etexilate) on a regular basis so as to avoid unnecessary deaths from fatal blood clots.

The study has been published in the New England Journal of Medicine.

Source-ANI
LIN